Dr. Brian A. Jonas is a Professor of Medicine and Interim Chief of the Division of Malignant Hematology/Cellular Therapy and Transplantation at UC Davis Comprehensive Cancer Center (UCDCCC). He specializes in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), acute lymphoblastic leukemia (ALL), and other myeloid malignancies. Dr. Jonas is a NIH-funded Clinician Scientist focusing on AML, MDS and ALL with an emphasis on early drug development. He chairs the UCDCCC Hematological Malignancies Disease Team Committee and is Chair of the UCDCCC Data and Safety Monitoring Committee. He sits on the NCCN panels for AML, MDS and ALL.